Penumbra, Inc Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Penumbra, Inc (PEN) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$712.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-07-30
- Penumbra, Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$712.00K, a 111.33% decline year-over-year.
- Penumbra, Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$2.27M, a 183.78% decline year-over-year.
- Penumbra, Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was $6.29M.
- Penumbra, Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-03-31 was $2.71M.
- Penumbra, Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $10.19M.
- Penumbra, Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$2.69M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|
| 2026-06-30 | -$712.00K 10-Q · filed 2026-07-30 | -$2.98M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | -$2.27M 10-Q · filed 2026-07-30 | ||
| 2025-12-31 | $10.19M 10-K · filed 2026-02-25 | ||
| 2025-06-30 | $6.29M 10-Q · filed 2026-07-30 | $9.00M 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $2.71M 10-Q · filed 2026-07-30 | ||
| 2024-12-31 | -$2.69M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |